UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$1.48B |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$690M |
| 3 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$588M |
| 4 |
Truist Financial
TFC
|
+$532M |
| 5 |
VanEck Gold Miners ETF
GDX
|
+$278M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.3B |
| 2 |
Alibaba
BABA
|
+$771M |
| 3 |
AABA
Altaba Inc
AABA
|
+$759M |
| 4 |
STI
SunTrust Banks, Inc.
STI
|
+$503M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$467M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.82% |
| 2 | Financials | 7.38% |
| 3 | Healthcare | 6.65% |
| 4 | Consumer Discretionary | 5.46% |
| 5 | Industrials | 5.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4951
Phathom Pharmaceuticals
PHAT
$699M
| $439K | ﹤0.01% |
+14,099
| New | +$354K |
|
|
INFN
4952
DELISTED
Infinera Corporation Common Stock
INFN
| $439K | ﹤0.01% |
55,260
-6,867
| -11% | -$42.2K |
|
4953
Banco Bilbao Vizcaya Argentaria
BBVA
$157B
| $438K | ﹤0.01% |
78,573
-150,924
| -66% | -$803K |
|
4954
Business First Bancshares
BFST
$1.04B
| $438K | ﹤0.01% |
17,585
+6,918
| +65% | +$170K |
|
4955
Ardmore Shipping
ASC
$668M
| $436K | ﹤0.01% |
48,232
+22,756
| +89% | +$189K |
|
4956
SmartFinancial
SMBK
$888M
| $436K | ﹤0.01% |
18,452
-2,744
| -13% | -$60.4K |
|
4957
WillScot Mobile Mini Holdings
WSC
$4.2B
| $436K | ﹤0.01% |
23,565
-35,388
| -60% | -$594K |
|
4958
Genie Energy
GNE
$382M
| $435K | ﹤0.01% |
56,254
+11,622
| +26% | +$91.1K |
|
|
PFNX
4959
DELISTED
Pfenex Inc.
PFNX
| $435K | ﹤0.01% |
39,575
+16,847
| +74% | +$167K |
|
4960
Transmedics
TMDX
$3.02B
| $434K | ﹤0.01% |
22,844
+11,348
| +99% | +$208K |
|
4961
Arcus Biosciences
RCUS
$3.69B
| $433K | ﹤0.01% |
42,871
+18,040
| +73% | +$152K |
|
|
SRE.PRA
4962
DELISTED
Sempra Energy 6% Mandatory Convertible Preferred Stock, Series A
SRE.PRA
| $433K | ﹤0.01% |
3,610
+946
| +36% | +$111K |
|
4963
Herbalife
HLF
$1.21B
| $432K | ﹤0.01% |
9,064
+4,777
| +111% | +$207K |
|
4964
IES Holdings
IESC
$15.1B
| $432K | ﹤0.01% |
16,809
+2,506
| +18% | +$54.2K |
|
|
XONE
4965
DELISTED
The ExOne Company
XONE
| $432K | ﹤0.01% |
57,970
-1,810
| -3% | -$12.9K |
|
4966
Medpace
MEDP
$16.9B
| $431K | ﹤0.01% |
5,124
+577
| +13% | +$44.7K |
|
4967
PUT
PNC Financial Services
PNC
$101B
| $431K | ﹤0.01% |
2,700
-300
| -10% | -$45K |
|
4968
SI-BONE Inc
SIBN
$858M
| $430K | ﹤0.01% |
19,995
+8,292
| +71% | +$149K |
|
4969
World Acceptance Corp
WRLD
$874M
| $430K | ﹤0.01% |
4,976
+4,351
| +696% | +$448K |
|
4970
Arlo Technologies
ARLO
$1.58B
| $429K | ﹤0.01% |
101,894
+38,264
| +60% | +$132K |
|
4971
Crinetics Pharmaceuticals
CRNX
$8.94B
| $429K | ﹤0.01% |
17,087
+7,888
| +86% | +$150K |
|
4972
Kura Oncology
KURA
$883M
| $429K | ﹤0.01% |
31,169
-47,500
| -60% | -$704K |
|
|
RESP
4973
DELISTED
WisdomTree U.S. ESG Fund
RESP
| $429K | ﹤0.01% |
11,619
+2,348
| +25% | +$83K |
|
|
DDF
4974
DELISTED
Delaware Investments Dividend & Income Fund, Inc.
DDF
| $429K | ﹤0.01% |
28,252
+2,137
| +8% | +$30.7K |
|
4975
CALL
Simply Good Foods
SMPL
$960M
| $428K | ﹤0.01% |
+15,000
| New | +$395K |
|
Similar funds
UBS Group's Q4 2019 Portfolio in Review
As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q4 2019 filing shows 808 new, 4,306 increased, 2,684 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.
By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9.5% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
- UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
- UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
- UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
- UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
- UBS Group opened 808 new positions and closed 688 in Q4 2019.
- UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.
Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.